{
    "organizations": [],
    "uuid": "b73c13b13601a1f3391860e61f18bf1f4e0a6594",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novartis-to-develop-digital-ms-sch/brief-novartis-to-develop-digital-ms-schizophrenia-therapeutics-with-pear-therapeutics-idUSFWN1QJ05C",
    "ord_in_thread": 0,
    "title": "Novartis to develop digital MS, schizophrenia therapeutics with Pear Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Novartis Ag:\n* NOVARTIS AND PEAR THERAPEUTICS TO DEVELOP DIGITAL THERAPEUTICS FOR PATIENTS WITH SCHIZOPHRENIA AND MULTIPLE SCLEROSIS\n* NOVARTIS INVESTED IN PEARâ€™S SERIES B ROUND OF FINANCING ANNOUNCED IN JANUARY 2018 (Reporting By Zurich newsroom)\n ",
    "published": "2018-03-01T14:31:00.000+02:00",
    "crawled": "2018-03-02T19:48:49.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "novartis",
        "ag",
        "novartis",
        "pear",
        "therapeutic",
        "develop",
        "digital",
        "therapeutic",
        "patient",
        "schizophrenia",
        "multiple",
        "sclerosis",
        "novartis",
        "invested",
        "pear",
        "series",
        "b",
        "round",
        "financing",
        "announced",
        "january",
        "reporting",
        "zurich",
        "newsroom"
    ]
}